OMIC Singular Genomics Corp: Bozor kapitallashuvining balans qiymatiga nisbati

Singular Genomics Systems Inc (OMIC) kompaniyasining rasmiy ramzlari

Singular Genomics Systems (OMIC) kompaniyasining nisbiy kapitalizatsiya ko'rsatkichi bozor kutuvlari va moddiy aktivlar o'rtasidagi muvozanatni namoyish etadi, bunda 0.41 qiymati joriy dinamikani aks ettiradi. Singular Genomics Systems uskunalarning ommaviy savdosini to'xtatganidan keyin o'z yetakchiligini korporativ texnologik gigantlarga boy berdi. Biznes "razor-and-blade" modeliga tayanib, mijozlarning sarflanadigan materiallarga bog'liqligini yaratgan edi. Cheklangan narx belgilash imkoniyati kompaniyani tor nishlar doirasida budjetli yechimlarni taklif qilishga majbur qildi.

Singular Genomics Corp (OMIC): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 01.03.2025gacha

OMIC (Singular Genomics Systems, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Singular Genomics Systems|OMIC - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Singular Genomics Systems Inc|OMIC - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Singular Genomics|OMIC - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati singulargenomics.com|OMIC - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Singular Genomics Systems|OMIC - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Singular Genomics Systems Inc|OMIC - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Singular Genomics Systems Inc
Fundamental baholash:OMIC, Singular Genomics Systems
Singular Genomics Systems, Inc. tomonidan chiqariladigan mahsulotlar

Ushbu ko'rsatkich barcha aksiyalarning umumiy bozor kapitalizatsiyasining kompaniyaning sof kapitaliga nisbati sifatida hisoblanadi. U investorlarning kompaniyaning moddiy aktivlariga nisbatan qanchalik ortiqcha to'lov qilayotganini aniqlaydi. Singular Genomics (OMIC) uchun ushbu farq G4 sekvenslash ekotizimining rivojlanishiga bo'lgan bozor kutuvlarini aks ettiradi. Kompaniyaning taxminiy qiymatining uning balans qiymatiga nisbati texnologik yetakchilik uchun to'lanadigan premiumni vizuallashtiradi. Ushbu egri chiziqni tahlil qilish haddan tashqari qimmat baholangan aktivlarni sotib olishdan qochishga yordam beradi.

Raqobatchilar tahlili

TEM (Tempus Labs) - Bozor kapitallashuvining balans qiymatiga nisbati|qiagen.com (QGEN) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati RGEN|Bozor qiymatining balans qiymatiga nisbati Avidity RNA|Kapitallashuvning balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|ultragenyx.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati BEAM (Beam Therapeutics)|SRPT - Balans qiymatiga nisbatan bozor kapitallashuvi|Twist Bio - Bozor kapitallashuvining balans qiymatiga nisbati|TXG (10x) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Intellia Therapeutics (NTLA)|Kapitallashuvning balans qiymatiga nisbati stoketherapeutics.com|BLFS: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Wave Life Sciences Ltd WVE|Kapitallashuvning sof aktivlarga nisbati MAZE (Maze Tx)|Sionna Corp - Bozor kapitallashuvining balans qiymatiga nisbati|PRME - Bozor qiymatining balans qiymatiga nisbati|TSHA - Bozor qiymatining balans qiymatiga nisbati|QURE: Bozor kapitallashuvining balans qiymatiga nisbati|MGTX (MeiraGTx Holdings) - Bozor kapitallashuvining balans qiymatiga nisbati|RGNX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Solid Corp (SLDB)|Ocugen, Inc. (OCGN) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati pacb.com (PACB)|BNTC (Benitec Biopharma) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Design Therapeutics Inc DSGN|RCKT (Rocket Pharmaceuticals Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|FDMT: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati lexeotx.com|KRRO (Korro Bio) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati EDIT (Editas Medicine)|Bozor qiymatining balans qiymatiga koeffitsiyenti SLN|Bozor qiymatining balans qiymatiga nisbati PRQR (ProQR Therapeutics N.V.)|Kapitallashuvning sof aktivlarga nisbati codexis.com (CDXS)|Bozor kapitallashuvining balans qiymatiga nisbati SGMO|Balans qiymatiga nisbatan bozor kapitallashuvi Nautilus Biotechnology, Inc. NAUT|MGX: Bozor kapitallashuvining balans qiymatiga nisbati|DTIL: Kapitallashuvning sof aktivlarga nisbati|generationbio.com - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Boundless Bio Inc|XCUR - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati IMNN|PHIO (Phio Pharmaceuticals) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi mustangbio.com MBIO|RNAZ: Kapitallashuvning sof aktivlarga nisbati|Bionano Genomics Inc. - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati APDN (Applied DNA Sciences)|bluebirdbio.com (BLUE) - Balans qiymatiga nisbatan bozor kapitallashuvi|IPA - Kapitallashuvning sof aktivlarga nisbati|Omega Therapeutics Inc (OMGA) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati RGLS (Regulus Therapeutics Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti SYRS|Bozor qiymatining balans qiymatiga nisbati TBIO (Telesis Bio, Inc.)|Kapitallashuvning sof aktivlarga nisbati TCON (traconpharma.com)|Bozor qiymatining balans qiymatiga nisbati UBX